Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group
- PMID: 33727699
- DOI: 10.1038/s41591-021-01299-5
Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group
Erratum in
-
Author Correction: Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group.Nat Med. 2021 May;27(5):925. doi: 10.1038/s41591-021-01360-3. Nat Med. 2021. PMID: 33948020 Free PMC article. No abstract available.
References
-
- World Health Organization. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand... (accessed 2 March 2021).
-
- Medicines and Healthcare products Regulatory Agency. https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval... (2 December 2020).
-
- U.S. Food & Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-takes-key-action... (11 December 2020).
-
- European Medicines Agency. https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-... (21 December 2020).
-
- World Health Organization. https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-... (31 December 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
